VisionCare Puts Off FDA Panel Review Of Eye Implant To Collect More Data
This article was originally published in The Gray Sheet
Executive Summary
Cancellation of an FDA panel review of VisionCare Ophthalmic Technologies' IMT implantable miniature telescope, which had been scheduled for April 24, gives the firm time to collect more long-term data
You may also be interested in...
Regulatory News In Brief
HHS creates Recovery Act office: Office of Recovery Act Coordination will "enhance and streamline" HHS' efforts to manage $137 billion in funding granted under the economic stimulus package, according to a March 11 announcement. The new office will be led by Dennis Williams, a 20-year veteran of the department who also will become HHS deputy assistant secretary for recovery act coordination. As of March 11, HHS has distributed $3 billion in Recovery Act funds for programs like Medicaid and Community Health Centers. The stimulus bill was signed by President Obama in February (1"The Gray Sheet" Feb. 16, 2009, p. 3)
Regulatory News In Brief
HHS creates Recovery Act office: Office of Recovery Act Coordination will "enhance and streamline" HHS' efforts to manage $137 billion in funding granted under the economic stimulus package, according to a March 11 announcement. The new office will be led by Dennis Williams, a 20-year veteran of the department who also will become HHS deputy assistant secretary for recovery act coordination. As of March 11, HHS has distributed $3 billion in Recovery Act funds for programs like Medicaid and Community Health Centers. The stimulus bill was signed by President Obama in February (1"The Gray Sheet" Feb. 16, 2009, p. 3)
LASIK Panel Reaches Consensus On Labeling Changes
Patient labeling for LASIK laser vision correction systems should be modified to include graphics of what potential visual side effects like halos and starbursts could look like, according to FDA's Ophthalmic Devices Panel